Chronic Ischemic cardiopathy archivos | Page 50 of 60

Antithrombotic Anticoagulants

Never ending controversy over the duration of post DES dual antiplatelet therapy

Original title: Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy- The SECURITY...

solaci - 15 January, 2015

Antithrombotic Anticoagulants

Risks and benefits of Dual Antiplatelet beyond the year of a drug-eluting stent

Original title: Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents. Reference: Laura Mauri et al....

solaci - 13 January, 2015

Chronic Ischemic cardiopathy

Hybrid Revascularization in Multiple Vessels

Original title: Hybrid Revascularization for Multivessel Coronary Artery Disease Reference: Mariuz Gassior, et al. J Am Cardiol Intv 2014;7:1277-83 According to...

solaci - 18 December, 2014

Chronic Ischemic cardiopathy

FFR results could change over the years

Original title: The impact of age flow reserve-guided percutaneous coronary intervention: A FAME (Fractional Flow Reserve versus Angiography...

solaci - 17 November, 2014

Chronic Ischemic cardiopathy

Despite the evidence, visual estimation continues to dominate the decision on intermediate lesions

Original title: Revascularization Decisions in Patients With Stable Angina and Intermediate Lesions. Results of the International Survey on...

solaci - 12 November, 2014

Chronic Ischemic cardiopathy

Target amount for reasonable incomplete revascularization

Original title: Reasonable incomplete revascularisation after percutaneouscoronary intervention: the SYNTAX Revascularisation Index. Reference: Philippe Généreux et al. EuroIntervention 2014;10-online publish-ahead-of-print.While...

solaci - 5 November, 2014

Chronic Ischemic cardiopathy

PCI Superior to Optimal Medical Treatment in Patients with Ischemic Cardiomyopathy

Original title: Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease. The FAME 2 Trial Investigators. Reference: Bernard De Bruyne...

solaci - 29 October, 2014

Chronic Ischemic cardiopathy

The higher the bleeding risk, the greater the benefit of radial access in terms of mortality

Original title: Baseline bleeding risk and arterial access site practice in relation to procedural outcomes after percutaneous coronary...

solaci - 14 October, 2014

Chronic Ischemic cardiopathy

Never ending controversy over the duration of post DES dual antiplatelet therapy

Risks and benefits of Dual Antiplatelet beyond the year of a drug-eluting stent

Hybrid Revascularization in Multiple Vessels

FFR results could change over the years

Despite the evidence, visual estimation continues to dominate the decision on intermediate lesions

Target amount for reasonable incomplete revascularization

PCI Superior to Optimal Medical Treatment in Patients with Ischemic Cardiomyopathy

The higher the bleeding risk, the greater the benefit of radial access in terms of mortality

Últimas Noticias

OPTION Trial: Left Atrial Appendage Closure

TRI-SPA Study: Tricuspid Edge-to-Edge Treatment

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

The El Salvador 2024 Sessions are coming soon

Check out the best images of the Arequipa 2024 Sessions

Accesos